Brief: VYNE Therapeutics FY Adjusted Net Income USD -25.147 Million

YARROW BIOSCIENCE

29/02/2024 13:00

Feb 29 (Reuters) - VYNE Therapeutics FY basic EPS USD -2.78.
* FY EPS from cont ops USD -2.72
* FY revenue USD 424 thousand
* FY net income USD -28.452 million